4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Agenus Inc. (AGEN) operates in the Biotechnology industry and is headquartered in Lexington, United States with about 81 employees. Its market capitalization is roughly $249 million. In the fiscal year ended 2025-12-31, AGEN reported $114M in revenue and $0M in net income.
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally.
Interactive charts & full statements → Open the AGEN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $114M | $104M | $156M | $98M | — |
| Gross Profit | $34M | ($53M) | ($81M) | ($99M) | — |
| Operating Income (EBIT) | ($21M) | ($124M) | ($160M) | ($180M) | — |
| Net Income | $0M | ($227M) | ($246M) | ($220M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $34M | $34M | $30M | $26M | $24M |
| Gross Profit | $22M | $27M | $6M | ($1M) | $2M |
| Operating Income (EBIT) | $15M | $14M | ($5M) | ($17M) | ($13M) |
| Net Income | $39M | ($11M) | $64M | ($28M) | ($25M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $227M | $226M | $314M | $414M | — |
| Total Liabilities | $505M | $533M | $462M | $468M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AGEN viewer.
About TickerBase · Data methodology & sources